WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004031390) VECTOR SYSTEM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/031390    International Application No.:    PCT/GB2003/004260
Publication Date: 15.04.2004 International Filing Date: 03.10.2003
IPC:
A61K 39/00 (2006.01), A61K 48/00 (2006.01), C12N 15/867 (2006.01)
Applicants: OXFORD BIOMEDICA (UK) LIMITED [GB/GB]; Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford OX4 4GA (GB) (For All Designated States Except US).
MAZARAKIS, Nicholas [GB/GB]; (GB) (For US Only).
AZZOUZ, Mimoun [MA/GB]; (GB) (For US Only).
BINLEY, Katie [GB/GB]; (GB) (For US Only).
NAYLOR, Stuart [GB/GB]; (GB) (For US Only).
KINGSMAN, Susan [GB/GB]; (GB) (For US Only)
Inventors: MAZARAKIS, Nicholas; (GB).
AZZOUZ, Mimoun; (GB).
BINLEY, Katie; (GB).
NAYLOR, Stuart; (GB).
KINGSMAN, Susan; (GB)
Agent: MALLALIEU, Catherine, Louise; D. Young & Co., 120 Holborn, London EC1N 2DY (GB)
Priority Data:
0223076.1 04.10.2002 GB
0228314.1 04.12.2002 GB
0318213.6 04.08.2003 GB
Title (EN) VECTOR SYSTEM
(FR) SYSTEME DE VECTEUR
Abstract: front page image
(EN)Use of a vector system to transduce a target site, wherein the vector system travels to the target site by diffusion, and wherein the vector system is or comprises at least part of a rabies G envelope protein or a mutant, variant, homologue or fragment thereof, or a CVS envelope protein or a mutant, variant, homologue or fragment thereof, and further wherein the target site is at least part of the central nervous system.
(FR)L'invention concerne l'utilisation d'un système de vecteur permettant d'effectuer une transduction vers un site cible. Ledit système de vecteur se déplace vers ledit site cible par diffusion. Ledit système de vecteur est ou comprend au moins une partie de protéine G d'enveloppe de la rage ou d'un mutant, d'un variant, d'un homologue ou d'un fragment de cette protéine. Le site cible est au moins une partie du système nerveux central.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)